Skip to main content
FDA Approves Pfizer’s Hympavzi for Hemophilia A, B
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA Approves Pfizer’s Hympavzi for Hemophilia A, B
User login
Username
Password
Reset your password
Concept
Lead
score
Hemophilia
1
1
Hemophilia A
0
0.97
Hemophilia B
0
0.74
Blood
0
0.29
Prophylaxis
0
0.29
Thrombus
0
0.27
Thromboembolism
0
0.25
Adverse Effects
0
0.1
Anticoagulation Therapy
0
0.1
Biologic Therapy
0
0.1
Factor II
0
0.1
Factor VIII
0
0.1
Food and Drug Administration (FDA)
0
0.1
Gene Therapy
0
0.1
Genomic Medicine
0
0.1
Headache
0
0.1
Hematology
0
0.1
Patient Safety
0
0.1
Tissue
0
0.1
Toxicology
0
0.1
Specialty
Lead
score
Family Medicine/Primary Care
1
1
Internal Medicine
0
1
Pharmacist
0
0.46
Cardiology
0
0.18
Neurology & Neurosurgery
0
0.18
Emergency Medicine
0
0.1
Public Health & Prevention
0
0.1
Edit Tags